P&I Investment
VC Fund
P&I Investment is a VC fund focused on Health Care and Information Technology. P&I Investment
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries P&I Investment invests in
Stages P&I Investment invests in
Countries P&I Investment invests in
Round sizes
Round size
- Venture - Series Unknown
- $840k–$3.1M
Investment Focus
Industry
- Health Care 2 (33%)
- Information Technology 2 (33%)
- Music 1 (17%)
- Gaming 1 (17%)
- Retail 1 (17%)
Stage
- Venture - Series Unknown 2 (33%)
- Seed 1 (17%)
- Series A 1 (17%)
- Series B 1 (17%)
- Funding Round 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Hwanghak-dong Online
|
Hwanghak-dong Online sells tables, chairs, water purifiers, refrigerators, and kitchen appliances. | Seed / Dec 29, 2021 | |
Humanscape
|
Humanscape is a rare disease health-tech company working to bring better chances of cure for patients. By collecting comprehensive patient health data from genotype, clinical to phenotype data and systematically compiling it into a complete, ready-to-use data set, pharmaceuticals and researchers can significantly reduce both time and cost for newdrug development. | $11.8M / Series B / Dec 08, 2020 | |
Kaipharm
|
KaiPharm Co., Ltd. develops unique drug virtual screening algorithm based on big data and artificial intelligence and provides comprehensive drug discovery solution. We build a multifaceted, integrated database of compound structures, drug-target relationships, drug-disease relationships, drug-induced transcriptome, and have unique data miningtechnologies. In-house database is the basis for developing artificial intelligence algorithms and providing complex solutions.One of the main project, KMAP, is to produce large drug-induced transcriptome by the next generation sequencing (NGS) and to find repositioning drugs. The KMAP use the method from the publicly available drug transcriptome pattern analysis (CMAP analysis), but expands the scope of analysis and increases the prediction accuracy because it not only produces proprietary data on its own, but also overcomes existing public data limitations by measuring the entire genes’ expression (21,000). We has conducted Internal researches for many years and accumulated analytical know-how.Secondly, for drug virtual screening service, we have two algorithm patents: BEAR registered in US & Korea, BACoN registered in Korea. These algorithms are unique technique that uses only large-scale drug screening data(bioactivity) without using any structural information on the compounds and targets. Uniqueness has been achieved through machine learning formula developed in-house, and the accuracy of prediction is improved by analyzing large data. | $4.2M / Series A / Jan 29, 2020 | |
|
Humanscape
|
Humanscape is a rare disease health-tech company working to bring better chances of cure for patients. By collecting comprehensive patient health data from genotype, clinical to phenotype data and systematically compiling it into a complete, ready-to-use data set, pharmaceuticals and researchers can significantly reduce both time and cost for newdrug development. | $840K / Venture - Series Unknown / Nov 04, 2019 | |
|
Humanscape
|
Humanscape is a rare disease health-tech company working to bring better chances of cure for patients. By collecting comprehensive patient health data from genotype, clinical to phenotype data and systematically compiling it into a complete, ready-to-use data set, pharmaceuticals and researchers can significantly reduce both time and cost for newdrug development. | $840K / Jul 19, 2019 | |
Mapiacompany
|
MAPIA, a Korea-based IT & Marketing enterprise with an affiliated business entity in Tokyo of Japan, is a recipient of “Forbes 30 Under 30 Asia 2018”, serving global users of 200 countries, our strategic partners include but not limited to global prominent copyright associations and publishers. We specialize in sheet music monetization, globalcontents distribution, and cross-border settlements facilitation.3 sheet music websites under MAPIA’s exclusive management as follows: MyMusicSheet https://www.mymusicsheet.com Mapianist https://www.mapianist.com Kokomu https://www.kokomu.jp | $3.1M / Venture - Series Unknown / Mar 08, 2019 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Featured in Investor Lists
Recommended lists
FAQ
What does P&I Investment invest in?
P&I Investment invests primarily in Health Care, Information Technology and Music startups, most often at Venture - Series Unknown and Seed stage. Most of the 6 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is P&I Investment's check size?
P&I Investment typically joins rounds of $840k–$3.1M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds P&I Investment participates in.
When did P&I Investment last invest?
The most recent investment recorded for P&I Investment closed in Dec 2021. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
